MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.intimp.2025.114106

Медицинская библиотека · International immunopharmacology · 2025

Evaluation of SB-83, a 2-amino-thiophene derivative, against Leishmania species that cause visceral leishmaniasis.

Rodrigues Raiza Raianne Luz, de Sousa Julyanne Maria Saraiva, Dos Santos Airton Lucas Sousa, de Souza Vanessa Maria Rodrigues, Machado Yasmim Alves Aires, de Lima Nunes Thaís Amanda, da Silva Marcos Vinícius, de Araújo-Nobre Alyne Rodrigues, de Araújo Rodrigo Santos Aquino, Mendonça Junior Francisco Jaime Bezerra, Veras Leiz Maria da Costa, Rodrigues Klinger Antonio da Franca

СтатьяПеревод в очереди

Аннотация

Visceral leishmaniasis is a systemic disease that affects various internal organs and represents the most severe and fatal form of leishmaniasis. Conventional treatment presents significant challenges, such as prolonged management in hospital settings, high toxicity, and an increasing growing number of cases of resistance. In previous studies, our research group demonstrated the effective and selective activity of the 2-amino-thiophene derivative SB-83 in preclinical models of cutaneous leishmaniasis. Given the urgent need for new therapeutic alternatives for visceral leishmaniasis, and considering our previous promising results for SB-83, this study investigated the antileishmanial activity of the compound on the etiological agents of visceral leishmaniasis. SB-83 demonstrated efficacy in inhibiting the growth of promastigote forms of Leishmania (Leishmania) infantum (IC50 = 7.46 µM) and Leishmania (Leishmania) donovani (IC50 = 9.84 µM). In the cytotoxicity evaluation, in RAW 264.7 macrophages, the compound revealed a CC50 = 52.27 µM, being more toxic to the parasite, and respective selectivity indices (SI) of 7 and 5.31 against the previously mentioned species. Atomic force microscopy analysis showed that the compound causes alterations in surface roughness, formation of englobulations, and accumulation of lipids, all of which are indicative of cell death by apoptosis. This was confirmed by flow cytometry, which showed an increase in the number of cells labeled with Annexin V-FITC+/IP-, indicating apoptosis. SB-83 showed even greater efficacy against intramacrophagic amastigote forms (EC50 = 2.91 µM), which was associated with structural changes, such as increased lysosomal volume, and cellular mechanisms, including elevated levels of cytokines TNF-α and IL-12, reactive oxygen and nitrogen species, and reduced levels of cytokines IL-10 and IL-6, as well as decreased arginase activity. The results allow us to conclude that the 2-amino-thiophene derivative SB-83 is a promising compound for development of new treatments against visceral leishmaniasis.

Для цитирования: Rodrigues Raiza Raianne Luz, de Sousa Julyanne Maria Saraiva, Dos Santos Airton Lucas Sousa, de Souza Vanessa Maria Rodrigues, Machado Yasmim Alves Aires, de Lima Nunes Thaís Amanda, da Silva Marcos Vinícius, de Araújo-Nobre Alyne Rodrigues, de Araújo Rodrigo Santos Aquino, Mendonça Junior Francisco Jaime Bezerra, Veras Leiz Maria da Costa, Rodrigues Klinger Antonio da Franca. Evaluation of SB-83, a 2-amino-thiophene derivative, against Leishmania species that cause visceral leishmaniasis.. International immunopharmacology. 2025. DOI: 10.1016/j.intimp.2025.114106.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.